|
|
|
10 Jan 2007 |
Mirus Bio Corporation Enters Into Agreement with Pfizer Inc to Evaluate RNAi Delivery Technology
|
|
10 Jan 2007 |
Organon partners with HUYA to identify and develop Chinese biopharmaceuticals
|
|
10 Jan 2007 |
Archemix Announces Collaboration with Pfizer to Discover Aptamer Therapeutics
|
|
09 Jan 2007 |
Ablynx and Boehringer Ingelheim sign $265 million research and licensing agreement to develop new Alzheimer's treatments
|
|
09 Jan 2007 |
PTC Therapeutics Announces Strategic Drug Discovery Collaboration With Pfizer Utilizing PTC’S Gems Technology Platform
|
|
09 Jan 2007 |
Seattle Genetics to Present at the JPMorgan Annual Healthcare Conference
|
|
09 Jan 2007 |
Seattle Genetics and Agensys Announce Collaboration to Co-Develop and Commercialize Antibody-Drug Conjugate Therapies for Cancer
|
|
08 Jan 2007 |
Catalyst Biosciences And Wyeth Pharmaceuticals Sign Two Agreements For Novel Biotherapeutic Platform Of Engineered Proteases
|
|
05 Jan 2007 |
Alkermes and Indevus Announce Joint Collaboration to Develop Inhaled Formulation of Trospium Chloride for the Treatment of COPD
|
|
04 Jan 2007 |
Five Prime enters Osteoarthritis and Pulmonary Fibrosis Collaboration with Centocor
|
|
03 Jan 2007 |
Galapagos expands and extends drug discovery collaboration with Amgen into 2008
|
|
27 Dec 2006 |
ImmunoGen, Inc. Announces that sanofi-aventis Has Entered into an Option Agreement for Expanded Access to the Company's TAP Technology
|
|
21 Dec 2006 |
MorphoSys Enlarges Therapeutic Antibody Collaboration with Pfizer - Expansion Doubles Potential Deal Volume for MorphoSys
|
|
20 Dec 2006 |
MediGene and Sanofi Pasteur Agree to Undertake a Collaborative Research Agreement to Develop High Affinity Monoclonal T cell receptors (mTCRs) for Vaccine Validation
|
|
19 Dec 2006 |
Exelixis and Bristol-Myers Squibb Sign New Collaboration Agreement to Discover and Develop Novel Oncology Compounds
|
|
19 Dec 2006 |
H. Lee Moffitt Cancer Center & Research Institute Announces New Research Initiative And Collaboration With Merck & Co., Inc.
|
|
15 Dec 2006 |
Peregrine Pharmaceuticals and Biotecnol to Collaborate on Development of Immunocytokine Fusion Proteins for Cancer and Anti-Viral Indications
|
|
13 Dec 2006 |
EASD, JDRF and Novo Nordisk join forces in new diabetes research programmes
|
|
12 Dec 2006 |
Merck & Co., Inc. and Idera Pharmaceuticals Sign Collaboration Agreement Incorporating Idera’s Toll-like Receptor Agonists in Merck’s Vaccine Programs
|
|
12 Dec 2006 |
Private UK Biotech Pharminox Signs $40 Million Drug Development Deal With Schering-Plough Corporation
|
|
08 Dec 2006 |
WuXi PharmaTech Co., Ltd. Announces Expanded Agreement With Merck & Co., Inc.
|
|
01 Dec 2006 |
VistaGen Therapeutics and Sanwa Renew Embryonic Stem Cell Drug Discovery and Development Partnership Focused on New Diabetes Treatments
|
|
30 Nov 2006 |
VisEn Medical Establishes Program to Develop and Apply Fluorescence in Vivo Imaging Technologies in Pharmaceutical R&D
|
|
29 Nov 2006 |
Applied NeuroSolutions Announces Agreement with Eli Lilly and Company to Develop Therapeutics to Treat Alzheimer’s Disease
|
|
21 Nov 2006 |
PARI and Kamada Collaborate to Develop Inhaled Alpha-1 Antitrypsin
|
|
21 Nov 2006 |
Cancer Research Technology and The University of Manchester Announce Clinical Pharmacology Collaboration in Oncology with AstraZeneca
|
|
21 Nov 2006 |
Artemis Pharmaceuticals GmBh (EXEL) Signs Agreement With Merck & Co., Inc. (MRK) For Generation Of Genetically Engineered In-Vivo RNAi Mouse Models
|
|
17 Nov 2006 |
Advinus Therapeutics and Merck & Co., Inc. Establish Drug Discovery and Development Collaboration
|
|
17 Nov 2006 |
KineMed and Merck Enter Clinical-Stage Collaboration to Evaluate Therapeutic Target Pharmacodynamics
|
|
15 Nov 2006 |
Cannasat Therapeutics and IntelGenx Enter into a Collaborative Agreement to Develop Novel Cannabinoid-based Products Based on Proprietary Drug Delivery Technologies
|
|
15 Nov 2006 |
Nautilus Biotech And Creabilis Therapeutics Achieve Technical Milestone In Collaboration To Improve HMGB1 Box A For The Treatment Of Rage- And HMGB1-Related Pathologies
|
|
08 Nov 2006 |
Medarex and PacMab Announce Therapeutic Antibody Co-Development Agreement
|
|
08 Nov 2006 |
Melior Announces Research Collaboration with Merck
|
|
07 Nov 2006 |
Ambit Biosciences Announces Discovery and Development Collaboration with Cephalon, Inc. Focused on Kinase Inhibitors
|
|
07 Nov 2006 |
Ablynx Enters into a Research and License Agreement with Wyeth
|
|
03 Nov 2006 |
XOMA and Takeda Establish Collaboration for Therapeutic Antibody Discovery and Development
|
|
03 Nov 2006 |
Gladstone Institute And Merck & Co., Inc. Announce Major Research Collaboration And Exclusive License Agreement In Field Of Apolipoprotein (Apo) E
|
|
27 Oct 2006 |
Idenix Pharmaceuticals Announces Strategic Collaboration To Enhance Hepatitis C Pipeline
|
|
27 Oct 2006 |
Sangamo BioSciences and JDRF Announce Partnership for ZFP Therapeutic for Diabetic Neuropathy Program
|
|
26 Oct 2006 |
Caprion Pharmaceuticals Announces Expansion of Biomarker Discovery Collaboration with Vertex Pharmaceuticals
|
|
24 Oct 2006 |
GenOdyssee SA Announces Research Partnership With Baxter AG
|
|
24 Oct 2006 |
Celldex Therapeutics and Ludwig Institute for Cancer Research Announce Cancer Antigen License and Clinical Research Collaboration
|
|
24 Oct 2006 |
Organon and BrainCells to collaborate in discovery and development of CNS drugs
|
|
18 Oct 2006 |
Merck KGaA and Glenmark Pharmaceuticals Announce Collaboration Agreement on DPPIV Inhibitor for Type 2 Diabetes
|
|
18 Oct 2006 |
CAT And MSM Protein Technologies Enter Drug Discovery Collaboration In The Field Of Multi-Spanning Membrane Proteins
|
|
17 Oct 2006 |
Daiichi Pharmaceutical Selects Evotec as Partner for Medicinal Chemistry and Compound Profiling
|
|
13 Oct 2006 |
Gene Logic Enters into Agreement with Lilly to Discover New Development Paths for Multiple Clinical Drug Candidates
|
|
11 Oct 2006 |
Inpharmatica Develops Target-Family Specific Knowledge Base for Schering AG
|
|
10 Oct 2006 |
Alligator Bioscience to Address Immunogenicity With Epibase(R)
|
|
10 Oct 2006 |
OMRIX Biopharmaceuticals Enters into a Cooperative Research and Development Agreement (CRADA) with the National Institute of Allergy and Infectious Diseases (NIAID) to Develop Antibody-Based Therapeutics for the Treatment of Influenza
|
| |
|
Results 251 - 300 of 530 |
